Occurrence and reduction of pharmaceuticals in the water phase at Swedish wastewater treatment plants
Publication: Research - peer-review › Journal article – Annual report year: 2012
Standard
Occurrence and reduction of pharmaceuticals in the water phase at Swedish wastewater treatment plants. / Falås, Per; La Cour Jansen, Jes; Ledin, Anna; Andersen, Henrik Rasmus.
In: Water Science and Technology, Vol. 66, No. 4, 2012, p. 783-791.Publication: Research - peer-review › Journal article – Annual report year: 2012
Harvard
APA
CBE
MLA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Occurrence and reduction of pharmaceuticals in the water phase at Swedish wastewater treatment plants
A1 - Falås,Per
A1 - La Cour Jansen,Jes
A1 - Ledin,Anna
A1 - Andersen,Henrik Rasmus
AU - Falås,Per
AU - La Cour Jansen,Jes
AU - Ledin,Anna
AU - Andersen,Henrik Rasmus
PB - I W A Publishing
PY - 2012
Y1 - 2012
N2 - During the last decade, several screening programs for pharmaceuticals at Swedish wastewater treatment plants (WWTPs) have been conducted by research institutes, county councils, and wastewater treatment companies. In this study, influent and effluent concentrations compiled from these screening programs were used to assess the occurrence and reduction of non-antibiotic pharmaceuticals for human usage. The study is limited to full-scale WWTPs with biological treatment. Based on the data compiled, a total of 70 non-antibiotic pharmaceuticals have been detected, at concentrations ranging from a few ng/L to several μg/L, in the influent water. The influent concentrations were compared with the sale volumes and for many pharmaceuticals it was shown that only a small fraction of the amount sold reaches WWTPs as dissolved parent compounds. Pharmaceuticals with low reduction degrees at traditional WWTPs were identified. Further comparison based on the biological treatment showed lower reduction degrees for several pharmaceuticals in trickling filter plants compared to activated sludge plants with nitrogen removal.
AB - During the last decade, several screening programs for pharmaceuticals at Swedish wastewater treatment plants (WWTPs) have been conducted by research institutes, county councils, and wastewater treatment companies. In this study, influent and effluent concentrations compiled from these screening programs were used to assess the occurrence and reduction of non-antibiotic pharmaceuticals for human usage. The study is limited to full-scale WWTPs with biological treatment. Based on the data compiled, a total of 70 non-antibiotic pharmaceuticals have been detected, at concentrations ranging from a few ng/L to several μg/L, in the influent water. The influent concentrations were compared with the sale volumes and for many pharmaceuticals it was shown that only a small fraction of the amount sold reaches WWTPs as dissolved parent compounds. Pharmaceuticals with low reduction degrees at traditional WWTPs were identified. Further comparison based on the biological treatment showed lower reduction degrees for several pharmaceuticals in trickling filter plants compared to activated sludge plants with nitrogen removal.
KW - Biological treatment
KW - Pharmaceuticals
KW - Wastewater treatment
U2 - 10.2166/wst.2012.243
DO - 10.2166/wst.2012.243
JO - Water Science and Technology
JF - Water Science and Technology
SN - 0273-1223
IS - 4
VL - 66
SP - 783
EP - 791
ER -